Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS‐CoV‐2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLLAlessandro Campanella, Paolo Ghia, Silvia Heltai et al.|American Journal of Hematology|2024Cited by 15